Clinical Trial Update: JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

View source ↗

Summary

Clinical trial update for the JAVEMACS study evaluating avelumab maintenance and continuous treatment in urothelial carcinoma in Japan. The study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Urothelial Carcinoma | Status: ACTIVE_NOT_RECRUITING